We are live on ! Find out more
CMD

Cantel Medical Corporation
CMD

Delisted

CMD was delisted on the 1st of June, 2021.

133 hedge funds and large institutions have $962M invested in Cantel Medical Corporation in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 62 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

41% more capital invested

Capital invested by funds: $680M → $962M (+$282M)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

2% more funds holding

Funds holding: 130133 (+3)

16% less call options, than puts

Call options by funds: $156K | Put options by funds: $186K

27% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 62

Holders
133
Holders Change
+3
Holders Change %
+2.31%
% of All Funds
4.31%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.16%
New
14
Increased
45
Reduced
62
Closed
10
Calls
$156K
Puts
$186K
Net Calls
-$30K
Net Calls Change
-$74K
Name Holding Trade Value Shares
Change
Change in
Stake
First Trust Advisors
76
First Trust Advisors
Illinois
$761K +$360K +13,544 +131%
EWM
77
Evercore Wealth Management
New York
$722K
CAM
78
Capstone Asset Management
Texas
$698K +$11.5K +433 +2%
ProShare Advisors
79
ProShare Advisors
Maryland
$682K -$14.5K -544 -2%
Federated Hermes
80
Federated Hermes
Pennsylvania
$680K -$75.4K -2,837 -12%
Barclays
81
Barclays
United Kingdom
$636K -$113K -4,233 -17%
BA
82
BlackRock Advisors
Delaware
$633K +$7.5K +282 +1%
BG
83
Bahl & Gaynor
Ohio
$628K -$106 -4 -0%
CS
84
Credit Suisse
Switzerland
$602K +$234K +8,796 +87%
VanEck Associates
85
VanEck Associates
New York
$569K -$112K -4,219 -19%
PP
86
PDT Partners
New York
$567K -$24.1K -907 -5%
VOYA Investment Management
87
VOYA Investment Management
Georgia
$553K
IAM
88
Impax Asset Management
New Hampshire
$446K +$372K +14,000 New
UBS AM
89
UBS AM
Illinois
$416K
COI
90
Connable Office Inc
Michigan
$396K -$17K -640 -5%
Thrivent Financial for Lutherans
91
Thrivent Financial for Lutherans
Minnesota
$385K +$7.98K +300 +3%
WFM
92
Wilmington Funds Management
Delaware
$380K
TRSOTSOK
93
Teachers Retirement System of the State of Kentucky
Kentucky
$373K
Susquehanna International Group
94
Susquehanna International Group
Pennsylvania
$364K -$31.5K -1,183 -9%
FMBTD
95
First Midwest Bank Trust Division
Illinois
$361K -$27 -1 -0%
Renaissance Technologies
96
Renaissance Technologies
New York
$349K -$191K -7,200 -40%
Nomura Holdings
97
Nomura Holdings
Japan
$337K +$283K +10,627 New
BNP Paribas Financial Markets
98
BNP Paribas Financial Markets
France
$289K -$61.9K -2,326 -20%
HHC
99
Hutchin Hill Capital
New York
$287K -$203K -7,650 -46%
ACM
100
Ashford Capital Management
Delaware
$276K -$49.2K -1,850 -18%

CMD Hedge Fund Activity: Q3 2013 in Review

133 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2013, worth a combined $962M — up 41% from $680M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CMD positions and 10 closed out — a net gain of 4 holders — while 45 added to existing stakes and 62 trimmed.

The largest buyer was GW&K Investment Management, opening a new position worth an estimated $6.27M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $3.74M sold.

  • 133 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2013, up from 130 in Q2 2013.
  • Funds reported $962M of Cantel Medical Corporation stock for Q3 2013, up 41% quarter-over-quarter.
  • 14 funds opened new Cantel Medical Corporation positions in Q3 2013 and 10 closed out, a net change of +4 holders.
  • The largest Cantel Medical Corporation buyer in Q3 2013 was GW&K Investment Management, an estimated $6.27M added.
  • The largest Cantel Medical Corporation seller in Q3 2013 was Allianz Asset Management, an estimated $3.74M sold.

Based on aggregated 13F filings for Q3 2013.